Industrial conglomerate 3M (NYSE: MMM) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 5.6% year on year to $6.5 billion. Its non-GAAP profit of $2.40 per share was 6.8% above analysts’ consensus estimates.

Is now the time to buy 3M? Find out by accessing our full research report, it’s free.

Company Overview

Producers of the first asthma inhaler, 3M Company (NYSE: MMM) is a global conglomerate known for products in industries like healthcare, safety, electronics, and consumer goods.

Revenue Growth

Reviewing a company’s long-term sales performance reveals insights into its quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. 3M’s demand was weak over the last five years as its sales fell at a 6.5% annual rate. This wasn’t a great result and suggests it’s a low quality business.

Long-term growth is the most important, but within industrials, a half-decade historical view may miss new industry trends or demand cycles. 3M’s annualized revenue growth of 3% over the last two years is above its five-year trend, which is encouraging.

3M also reports organic revenue, which strips out one-time events like acquisitions and currency fluctuations that don’t accurately reflect its fundamentals. Over the last two years, 3M’s organic revenue averaged 2.1% year-on-year growth. Because this number aligns with its two-year revenue growth, we can see the company’s core operations (not acquisitions and divestitures) drove most of its results.

This quarter, 3M reported year-on-year revenue growth of 5.6%, and its $6.5 billion of revenue exceeded Wall Street’s estimates by 1.5%.

Looking ahead, sell-side analysts expect revenue to grow 2.9% over the next 12 months, similar to its two-year rate. This projection doesn’t excite us and implies its newer products and services will not lead to better top-line performance yet.

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.

Operating Margin

Operating margin is one of the best measures of profitability because it tells us how much money a company takes home after procuring and manufacturing its products, marketing and selling those products, and most importantly, keeping them relevant through research and development.

3M has done a decent job managing its cost base over the last five years. The company has produced an average operating margin of 8.6%, higher than the broader industrials sector.

Analyzing the trend in its profitability, 3M’s operating margin rose by 3.5 percentage points over the last five years, showing its efficiency has improved.

This quarter, 3M generated an operating margin profit margin of 15.1%, down 3.4 percentage points year on year. Since 3M’s operating margin decreased more than its gross margin, we can assume it was less efficient because expenses such as marketing, R&D, and administrative overhead increased.

Earnings Per Share

We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.

Sadly for 3M, its EPS and revenue declined by 3.4% and 6.5% annually over the last five years. We tend to steer our readers away from companies with falling revenue and EPS, where diminishing earnings could imply changing secular trends and preferences. If the tide turns unexpectedly, 3M’s low margin of safety could leave its stock price susceptible to large downswings.

Like with revenue, we analyze EPS over a more recent period because it can provide insight into an emerging theme or development for the business.

For 3M, its two-year annual EPS declines of 4.7% show it’s continued to underperform. These results were bad no matter how you slice the data.

In Q2, 3M reported adjusted EPS of $2.40, up from $2.16 in the same quarter last year. This print beat analysts’ estimates by 6.8%. Over the next 12 months, Wall Street expects 3M’s full-year EPS to grow 5.5% from $8.56 to $9.03.

Key Takeaways from 3M’s Q2 Results

We enjoyed seeing 3M beat analysts’ organic revenue expectations this quarter. We were also glad its full-year EPS guidance exceeded Wall Street’s estimates. Zooming out, we think this was a good print with some key areas of upside. The stock traded up 5.7% to $168.50 immediately following the results.

Sure, 3M had a solid quarter, but if we look at the bigger picture, is this stock a buy? We think that the latest quarter is only one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).